Group Menu ->
Home
Search
Careers
Investors
News
Contact Us
×
No Results
Global
Australia
Austria
Azerbaijan
Brazil
Belgium
Canada
Chile
China
Costa Rica
Croatia
Czech Republic
Denmark
ESTONIA
Finland
France
Germany
Hong Kong
Hungary
India
Italy
Ireland
Japan
Korea
Latvia
Lithuania
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Philippines
Poland
Portugal
Romania
Singapore
Slovakia
Slovenia
Spain
Sweden
Switzerland
Taiwan
Turkey
United Kingdom
UNITED ARAB EMIRATES
United States
Vietnam
Menu
Home
Our Services
Agroscience Services
About Us
Field Studies
Chemistry
Ecotoxicology
Regulatory Affairs
Contacts
Agro Testing
Assurance
BioPharma Services
Bioanalytical Services
BioPharma Product Testing
Contract Development & Manufacturing Organisation (CDMO)
Pharma Discovery Services
Pharma Early Development
Pharma Central Laboratory
Medical Device Testing
Human Safety Testing
Clinical Diagnostics
Europe
India
USA
Contacts
Search Clinical Diagnostics
Consumer Product Testing
Industries
Services
Information
News
About Us
Cosmetics & Personal Care
Electrical & Electronics
Environment Testing
Water Testing
Air Testing
Soil Testing
Building Materials
Pollution Testing
Waste Testing
Fuel / Oil Testing
Environment Laboratories
Environmental Testing News
Food and Feed Testing
Food Testing Services
Food Testing Industries
Food Testing Flyers
Food Testing Laboratories
Forensic Services
Forensic DNA Analysis
Forensic toxicology
Quality and Safety
Genomic Services
Next Generation Sequencing
Gene Synthesis & Molecular Biology
Genotyping & Gene Expression
DNA & RNA Oligonucleotides
Custom DNA Sequencing
News & Events
About Us
In Vitro Diagnostics Solutions
Maritime Services
Materials and Engineering
PSS Insourcing Solutions ®
REACH Services
About Us
Testing Services
Regulatory Affairs
Industries
News and useful links
Contact Us
Sensory and Consumer Research
Sustainability Services
About Us
Our Business
Eurofins Fact Sheet
Eurofins Group overview
Eurofins Strategy and Objectives
Eurofins Entrepreneurship Model
Eurofins History
30th Anniversary (2017)
Our Vision, Mission and Values
Our Leadership
Leadership Charter
Board of Directors
Group Operating Council
Corporate Sustainability
Eurofins Foundation
Environment
CO2 Emissions
ISO 14001 (Environmental Management)
Spotlight: Examples of Local Environmental Initiatives
Social and Employee Matters
Recruitment
Training and Academy
Diversity
FT Diversity Leader by Financial Times
OHSAS 18001 / ISO 45001 (Occupational Health and Safety)
Total Recordable Incidence Rate (TRIR)
Spotlight: Examples of Local Social Initiatives
Governance
Code of Ethics and Values
Eurofins Core Compliance Documents
Whistleblowing
Our Approach to Corporate Sustainability
Giving Back
Carbon Neutrality - 2025 Objective
Our Commitment to the UN Sustainable Development Goals
Scientific Collaborations
Your Career at Eurofins
Our Global Locations
COVID-19-Response
Scientific Impact
Testing for Life
Scientific Innovation
A New Era of Oncological Data
Fighting an Animal Health Endemic
20 Million Tests a Month to Help Protect the World Against COVID-19
Protecting Crops and Human Health at the Same Time
Ensuring Liquid Gold is the Real Deal
Detecting a Silent Threat – Transplant Rejection
What Do Pizza Boxes, Raincoats and Frying Pans Have in Common?
Seeking Out a Silent Killer
Protecting Cancer Patients
Safeguarding the Health of the World’s Most Vulnerable Consumers – Infants
Tackling the Big Problem of Tiny Particles
Protecting Transplant Patients and Saving Lives
Busting the Identical Twin Myth
New Generation of Non-Invasive Prenatal Testing Methods
SNIF-NMR - How it All Began
The Future of Bees, the Future of Life
Helping to stop Zika in its tracks
A Pioneer in Dioxins Detection
Acrylamide on the Tip of Everyone’s Tongue
Fuelling the First Astronauts
Testing for Traceability of Meat From Farm to Fork Down to Individual Animals
The Forefathers of Pesticide Testing
30 Years of Data for Life
Finding Adulteration Even When Not Looking for it
Modern Farming is Precision Farming
Beating Drug-Assisted Rape Forensically
High-Flying Innovation
Testing for Tailored Cancer Treatment
Nurturing Cells to Grow
Out of the Box Product Testing
Inventing The Most Sensitive Heavy Metals Detection Method
A Passive Revolution In Water Sampling
Algae, Algae, Everywhere. Toxic and What a Stink
Solving Old Crimes with New Technology
Leading the World in GM Fish Detection
Not Wanted Dead or Alive Mould and Bacteria
Salmon under Threat – Detecting a New Contaminant of Concern
Scientific Publications
Downloads
Investors
Shareholder Information
Reports and Presentations
2023
2024
Our Success in Numbers
Board Committees
Audit and Risk Committee
Sustainability and Corporate Governance Committee
Nomination and Remuneration Committee
Executives’ Dealings Disclosures
Analyst Coverage
Shares in Issue
Corporate Timetable
Debt & Hybrid Capital Instruments
Bond Instruments
Hybrid Capital Instruments
Bond & Hybrid Capital Maturity Profile
Credit Presentations
2021
2020
2019
2017
2016
2015
Commercial Paper Program
Rating
Investor Relations Events Timetable
AGM 2024
Prior shareholder meetings
AGM 2023
Share buy-back programmes
Eurofins response to MW
Media Centre
Press Releases
Newsletters
Eurofins BioPharma Services Newsletter 34 - February 2023
Eurofins BioPharma Services Newsletter 33 - October 2022
Eurofins BioPharma Services Newsletter 32 - June 2022
Eurofins BioPharma Services Newsletter 31 - February 2022
Eurofins BioPharma Services Newsletter 30 - October 2021
Eurofins BioPharma Services Newsletter 29 - June 2021
Eurofins BioPharma Services Newsletter 28 - February 2021
Eurofins BioPharma Services Newsletter 27 - October 2020
Eurofins BioPharma Services Newsletter 26 - July 2020
Eurofins BioPharma Services Newsletter 25 - February 2020
Eurofins BioPharma Services Newsletter 24 - October 2019
Eurofins BioPharma Services Newsletter 23 - June 2019
Eurofins BioPharma Services Newsletter 22 - February 2019
Downloads
Contact Us
Group Directory PDF
Worldwide Interactive Map
Argentina
Australia
Austria
Bahrain
Bangladesh
Belgium
Brazil
Bulgaria
Cambodia
Canada
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
Denmark
Estonia
Finland
France
French Guiana
Germany
Greece
Hong Kong (China)
Hungary
India
Indonesia
Ireland
Israel
Italy
Japan
Korea
Lithuania
Luxembourg
Malaysia
Martinique
Mauritius
Morocco
Myanmar
The Netherlands
New Zealand
Norway
Pakistan
Philippines
Poland
Portugal
Romania
Saudi Arabia
Singapore
Slovakia
Slovenia
South Africa
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Thailand
Tunisia
Turkey
United Arab Emirates
United Kingdom
USA
Vietnam
Our Services
Agroscience Services
Agro Testing
Assurance
BioPharma Services
Clinical Diagnostics
Consumer Product Testing
Cosmetics & Personal Care
Electrical & Electronics
Environment Testing
Food and Feed Testing
Forensic Services
Genomic Services
In Vitro Diagnostics Solutions
Maritime Services
Materials and Engineering
PSS Insourcing Solutions ®
REACH Services
Sensory and Consumer Research
Sustainability Services
About Us
Our Business
Our Vision, Mission and Values
Our Leadership
Corporate Sustainability
Your Career at Eurofins
Our Global Locations
COVID-19-Response
Scientific Impact
Testing for Life
Scientific Innovation
Scientific Publications
Downloads
Investors
Shareholder Information
Reports and Presentations
Our Success in Numbers
Board Committees
Executives’ Dealings Disclosures
Analyst Coverage
Shares in Issue
Corporate Timetable
Debt & Hybrid Capital Instruments
Investor Relations Events Timetable
AGM 2024
Share buy-back programmes
Eurofins response to MW
Media Centre
Press Releases
Newsletters
Downloads
Contact Us
Group Directory PDF
Worldwide Interactive Map
Eurofins
>>
Media Centre
>> Press Releases
Eurofins
>>
Media Centre
>> Press Releases
Search >>
Our Services
Agroscience Services
About Us
Field Studies
Chemistry
Ecotoxicology
Regulatory Affairs
Contacts
Agro Testing
Assurance
BioPharma Services
Bioanalytical Services
BioPharma Product Testing
Contract Development & Manufacturing Organisation (CDMO)
Pharma Discovery Services
Pharma Early Development
Pharma Central Laboratory
Medical Device Testing
Human Safety Testing
Clinical Diagnostics
Europe
India
USA
Contacts
Search Clinical Diagnostics
Consumer Product Testing
Industries
Services
Information
News
About Us
Cosmetics & Personal Care
Electrical & Electronics
Environment Testing
Water Testing
Air Testing
Soil Testing
Building Materials
Pollution Testing
Waste Testing
Fuel / Oil Testing
Environment Laboratories
Environmental Testing News
Food and Feed Testing
Food Testing Services
Food Testing Industries
Food Testing Flyers
Food Testing Laboratories
Forensic Services
Forensic DNA Analysis
Forensic toxicology
Quality and Safety
Genomic Services
Next Generation Sequencing
Gene Synthesis & Molecular Biology
Genotyping & Gene Expression
DNA & RNA Oligonucleotides
Custom DNA Sequencing
News & Events
About Us
In Vitro Diagnostics Solutions
Maritime Services
Materials and Engineering
PSS Insourcing Solutions ®
REACH Services
About Us
Testing Services
Regulatory Affairs
Industries
News and useful links
Contact Us
Sensory and Consumer Research
Sustainability Services
About Us
Our Business
Eurofins Fact Sheet
Eurofins Group overview
Eurofins Strategy and Objectives
Eurofins Entrepreneurship Model
Eurofins History
30th Anniversary (2017)
Our Vision, Mission and Values
Our Leadership
Leadership Charter
Board of Directors
Group Operating Council
Corporate Sustainability
Eurofins Foundation
Environment
CO2 Emissions
ISO 14001 (Environmental Management)
Spotlight: Examples of Local Environmental Initiatives
Social and Employee Matters
Recruitment
Training and Academy
Diversity
FT Diversity Leader by Financial Times
OHSAS 18001 / ISO 45001 (Occupational Health and Safety)
Total Recordable Incidence Rate (TRIR)
Spotlight: Examples of Local Social Initiatives
Governance
Code of Ethics and Values
Eurofins Core Compliance Documents
Whistleblowing
Our Approach to Corporate Sustainability
Giving Back
Carbon Neutrality - 2025 Objective
Our Commitment to the UN Sustainable Development Goals
Scientific Collaborations
Your Career at Eurofins
Our Global Locations
COVID-19-Response
Scientific Impact
Testing for Life
Scientific Innovation
A New Era of Oncological Data
Fighting an Animal Health Endemic
20 Million Tests a Month to Help Protect the World Against COVID-19
Protecting Crops and Human Health at the Same Time
Ensuring Liquid Gold is the Real Deal
Detecting a Silent Threat – Transplant Rejection
What Do Pizza Boxes, Raincoats and Frying Pans Have in Common?
Seeking Out a Silent Killer
Protecting Cancer Patients
Safeguarding the Health of the World’s Most Vulnerable Consumers – Infants
Tackling the Big Problem of Tiny Particles
Protecting Transplant Patients and Saving Lives
Busting the Identical Twin Myth
New Generation of Non-Invasive Prenatal Testing Methods
SNIF-NMR - How it All Began
The Future of Bees, the Future of Life
Helping to stop Zika in its tracks
A Pioneer in Dioxins Detection
Acrylamide on the Tip of Everyone’s Tongue
Fuelling the First Astronauts
Testing for Traceability of Meat From Farm to Fork Down to Individual Animals
The Forefathers of Pesticide Testing
30 Years of Data for Life
Finding Adulteration Even When Not Looking for it
Modern Farming is Precision Farming
Beating Drug-Assisted Rape Forensically
High-Flying Innovation
Testing for Tailored Cancer Treatment
Nurturing Cells to Grow
Out of the Box Product Testing
Inventing The Most Sensitive Heavy Metals Detection Method
A Passive Revolution In Water Sampling
Algae, Algae, Everywhere. Toxic and What a Stink
Solving Old Crimes with New Technology
Leading the World in GM Fish Detection
Not Wanted Dead or Alive Mould and Bacteria
Salmon under Threat – Detecting a New Contaminant of Concern
Scientific Publications
Downloads
Investors
Shareholder Information
Reports and Presentations
2023
2024
Our Success in Numbers
Board Committees
Audit and Risk Committee
Sustainability and Corporate Governance Committee
Nomination and Remuneration Committee
Executives’ Dealings Disclosures
Analyst Coverage
Shares in Issue
Corporate Timetable
Debt & Hybrid Capital Instruments
Bond Instruments
Hybrid Capital Instruments
Bond & Hybrid Capital Maturity Profile
Credit Presentations
2021
2020
2019
2017
2016
2015
Commercial Paper Program
Rating
Investor Relations Events Timetable
AGM 2024
Prior shareholder meetings
AGM 2023
Share buy-back programmes
Eurofins response to MW
Media Centre
Press Releases
Newsletters
Eurofins BioPharma Services Newsletter 34 - February 2023
Eurofins BioPharma Services Newsletter 33 - October 2022
Eurofins BioPharma Services Newsletter 32 - June 2022
Eurofins BioPharma Services Newsletter 31 - February 2022
Eurofins BioPharma Services Newsletter 30 - October 2021
Eurofins BioPharma Services Newsletter 29 - June 2021
Eurofins BioPharma Services Newsletter 28 - February 2021
Eurofins BioPharma Services Newsletter 27 - October 2020
Eurofins BioPharma Services Newsletter 26 - July 2020
Eurofins BioPharma Services Newsletter 25 - February 2020
Eurofins BioPharma Services Newsletter 24 - October 2019
Eurofins BioPharma Services Newsletter 23 - June 2019
Eurofins BioPharma Services Newsletter 22 - February 2019
Downloads
Contact Us
Group Directory PDF
Worldwide Interactive Map
Argentina
Australia
Austria
Bahrain
Bangladesh
Belgium
Brazil
Bulgaria
Cambodia
Canada
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
Denmark
Estonia
Finland
France
French Guiana
Germany
Greece
Hong Kong (China)
Hungary
India
Indonesia
Ireland
Israel
Italy
Japan
Korea
Lithuania
Luxembourg
Malaysia
Martinique
Mauritius
Morocco
Myanmar
The Netherlands
New Zealand
Norway
Pakistan
Philippines
Poland
Portugal
Romania
Saudi Arabia
Singapore
Slovakia
Slovenia
South Africa
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Thailand
Tunisia
Turkey
United Arab Emirates
United Kingdom
USA
Vietnam
Press Releases
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Archive
Date
Latest News
PDF
3-Jul-2024
Eurofins refutes baseless allegations and misleading information spread by Muddy Waters
25-Jun-2024
Eurofins responds to Muddy Waters Report
13-May-2024
The Eurofins network expands battery testing services, supporting client acceleration of battery innovation
24-Apr-2024
Eurofins achieves organic growth of 6.8% in Q1 2024, ahead of its objectives
3-Apr-2024
The Eurofins network expands its offering in renal and transplant testing in the United States with the acquisition of Ascend Clinical LLC
29-Feb-2024
Eurofins Discovery Introduces Innovative DiscoveryAI SAFIRE: A New AI-Driven Platform for Drug Discovery Trained Using Proprietary Datasets
27-Feb-2024
Eurofins delivers strong margin improvement and cash generation in H2 2023 and annual results in line with its 2023 objectives. Remains confident to achieve its 2027 objectives.
<<
<
1
2
>
>>
Contact Us